MYGN

5.4601.44%
SS

Samraat S. Raha

President, CEO & Director

Mr. Samraat S. Raha, also known as Sam, is Independent Director of Araceli Biosciences Inc. He served as Chief Operating Officer at Myriad Genetics, Inc. since December 11, 2023 until April 30, 2025 and serves as its President, Chief Executive Officer and Director since April 30, 2025. He serves as Chief Business Officer at Luminex Madison. He served as the Senior Vice President of Agilent Technologies, Inc. since May 01, 2017 until 2023 and served as its President of Diagnostics & Genomics Group until 2023. Mr. Raha joins EraGen Biosciences from his position as Vice President of Discovery Services at Incyte Genomics where he was responsible for Incyte's genomic service businesses including microarrays and bioreagents. Mr. Raha served as the Executive at Incyte Corporation. Prior to Agilent, he was Vice President of Global Marketing at Illumina. Mr. Raha started with Incyte in 1994, before it had any pharmaceutical partners and played a key role in shaping and growing Incyte's world-class high throughput sequencing operation. In 1998, he established Incyte's custom sequencing business that he grew to serve more than fifty commercial customers in over ten countries. Mr. Raha received his B.A. in Molecular and Cell Biology from the University of California at Berkeley and earned his MBA from Santa Clara University.

Positions